BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Clinical trial NCT01791478 · UNKNOWN

Trial details

NCT number: NCT01791478
Sponsor: Vanderbilt-Ingram Cancer Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Estrogen Receptor-positive Breast Cancer HER2-negative Breast Cancer Invasive Ductal Breast Carcinoma Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2013-04-01
Primary completion: 2014-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.